Photo 3 (IMAGE)

The University of Hong Kong

Photo 3

Caption

The new drug screening platform ‘Liver-in-Cube’ is developed using cells and tissue from liver cancer patients. The platform accurately simulates the tumour characteristics of individual patients, allowing continuous drug tests and evaluation of the effects of various therapies on the bench.

Credit

The University of Hong Kong

Usage Restrictions

n/a

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.